GREENLIGHT CAPITAL RE, LTD.
For the period ended Sep 30, 2025. Filed Nov 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, 2025 (unaudited) and December 31, 2024
(expressed in thousands of U.S. dollars, except per share and share amounts)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Investments | ||
| Investment in related party investment fund, at fair value | $456,861 | $387,144 |
| Other investments | 63,182 | 73,160 |
| Total investments | 520,043 | 460,304 |
| Cash and cash equivalents | 68,789 | 64,685 |
| Restricted cash and cash equivalents | 586,444 | 584,402 |
| Reinsurance balances receivable | 731,707 | 704,483 |
| Reinsurance recoverable on unpaid loss and loss adjustment expenses | 82,783 | 85,790 |
| Deferred acquisition costs | 98,476 | 82,249 |
| Unearned premiums ceded | 36,123 | 29,545 |
| Other assets | 9,690 | 4,765 |
| Total assets | $2,134,055 | $2,016,223 |
| Liabilities and equity | ||
| Liabilities | ||
| Loss and loss adjustment expense reserves | $938,308 | $860,969 |
| Unearned premium reserves | 379,274 | 324,551 |
| Reinsurance balances payable | 97,980 | 105,892 |
| Funds withheld | 15,139 | 21,878 |
| Other liabilities | 9,720 | 6,305 |
| Debt | 34,745 | 60,749 |
| Total liabilities | 1,475,166 | 1,380,344 |
| Commitments and Contingencies (Note 15) | ||
| Shareholders' equity | ||
| Preferred share capital (par value $0.10; none issued) | — | — |
| Ordinary share capital (par value $0.10; issued and outstanding, 34,099,226) (2024: par value $0.10; issued and outstanding, 34,831,324) | 3,394 | 3,483 |
| Additional paid-in capital | 479,099 | 481,551 |
| Retained earnings | 176,396 | 150,845 |
| Total shareholders' equity | 658,889 | 635,879 |
| Total liabilities and equity | $2,134,055 | $2,016,223 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the three and nine months ended September 30, 2025 and 2024
(expressed in thousands of U.S. dollars, except per share and share amounts)
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenues | ||||
| Gross premiums written | $184,377 | $168,346 | $611,950 | $554,579 |
| Gross premiums ceded | (21,695) | (26,598) | (65,344) | (64,611) |
| Net premiums written | 162,682 | 141,748 | 546,606 | 489,968 |
| Change in net unearned premium reserves | 2,737 | 10,136 | (51,083) | (18,150) |
| Net premiums earned | 165,419 | 151,884 | 495,523 | 471,818 |
| Income (loss) from investment in related party investment fund (Note 3) | (14,404) | 19,844 | (483) | 42,422 |
| Net investment income (loss) | (2,950) | 10,454 | 15,807 | 34,580 |
| Foreign exchange gains (losses) | (1,994) | 5,826 | 8,632 | 3,245 |
| Other income | — | — | — | 2,119 |
| Total revenues | 146,071 | 188,008 | 519,479 | 554,184 |
| Expenses | ||||
| Net loss and loss adjustment expenses incurred | 88,593 | 93,165 | 311,556 | 304,524 |
| Acquisition costs | 46,962 | 46,162 | 140,676 | 138,226 |
| Underwriting expenses | 7,472 | 6,073 | 20,311 | 18,223 |
| Corporate and other expenses | 5,399 | 4,253 | 14,826 | 13,334 |
| Deposit interest expense | 94 | 377 | 367 | 3,139 |
| Interest expense | 1,430 | 2,018 | 4,038 | 4,827 |
| Total expenses | 149,950 | 152,048 | 491,774 | 482,273 |
| Income (loss) before income tax | (3,879) | 35,960 | 27,705 | 71,911 |
| Income tax expense | (526) | (723) | (2,154) | (1,677) |
| Net income (loss) | $(4,405) | $35,237 | $25,551 | $70,234 |
| Earnings (Loss) per share ("EPS"): | ||||
| Basic | $(0.13) | $1.03 | $0.75 | $2.05 |
| Diluted | $(0.13) | $1.01 | $0.74 | $2.02 |
| Weighted average number of ordinary shares used in the determination of EPS: | ||||
| Basic | 33,760,337 | 34,120,955 | 33,892,806 | 34,210,560 |
| Diluted | 33,760,337 | 34,810,066 | 34,477,322 | 34,824,372 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
For the three and nine months ended September 30, 2025 and 2024
(expressed in thousands of U.S. dollars)
| Three months ended September 30 | Nine months ended September 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Ordinary share capital | ||||
| Balance - beginning of period | $3,420 | $3,532 | $3,483 | $3,534 |
| Issued (forfeited) shares, net | (10) | 6 | (37) | 4 |
| Repurchase of ordinary shares | (16) | (55) | (52) | (55) |
| Balance - end of period | 3,394 | 3,483 | 3,394 | 3,483 |
| Additional paid-in capital | ||||
| Balance - beginning of period | 479,097 | 487,462 | 481,551 | 484,532 |
| Repurchase of ordinary shares | (1,984) | (7,433) | (6,948) | (7,433) |
| Share-based compensation expense | 1,986 | 1,643 | 4,496 | 4,573 |
| Balance - end of period | 479,099 | 481,672 | 479,099 | 481,672 |
| Retained earnings | ||||
| Balance - beginning of period | 180,801 | 143,026 | 150,845 | 108,029 |
| Net income (loss) | (4,405) | 35,237 | 25,551 | 70,234 |
| Balance - end of period | 176,396 | 178,263 | 176,396 | 178,263 |
| Total shareholders' equity | $658,889 | $663,418 | $658,889 | $663,418 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended September 30, 2025 and 2024
(expressed in thousands of U.S. dollars)
| Nine months ended September 30 | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net income | $25,551 | $70,234 |
| Adjustments to reconcile net income or loss to net cash provided by operating activities: | ||
| Loss (income) from investments in related party investment fund | 483 | (42,422) |
| Net realized and unrealized losses on other investments | 11,731 | 324 |
| Net realized and unrealized losses (gains) on derivatives | (13) | 58 |
| Share-based compensation expense | 4,459 | 4,577 |
| Accretion of debt offering costs, net of change in interest accruals | (691) | 1,177 |
| Depreciation expense | 44 | — |
| Net change in: | ||
| Reinsurance balances receivable | (27,224) | (99,318) |
| Reinsurance recoverable on unpaid loss and loss adjustment expenses | 3,007 | (40,260) |
| Deferred acquisition costs | (16,227) | (2,250) |
| Unearned premiums ceded | (6,578) | (18,009) |
| Loss and loss adjustment expense reserves | 77,339 | 149,598 |
| Unearned premium reserves | 54,723 | 40,793 |
| Reinsurance balances payable | (7,912) | 19,169 |
| Funds withheld | (6,739) | 3,499 |
| Other items, net | (1,953) | (5,200) |
| Net cash provided by operating activities | 110,000 | 81,970 |
| Cash flows from investing activities | ||
| Proceeds from redemptions of investment in Solasglas | 14,000 | 14,000 |
| Contributions to investment in Solasglas | (84,200) | (110,576) |
| Purchases of other investments | (2,737) | (814) |
| Proceeds from sale of other investments | 984 | 168 |
| Purchases of other assets | (252) | — |
| Net cash used in investing activities | (72,205) | (97,222) |
| Cash flows from financing activities | ||
| Repayment of debt | (25,313) | (11,876) |
| Repurchase of ordinary shares | (7,000) | (7,488) |
| Net cash used in financing activities | (32,313) | (19,364) |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 664 | 619 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 6,146 | (33,997) |
| Cash, cash equivalents and restricted cash at beginning of the period | 649,087 | 655,730 |
| Cash, cash equivalents and restricted cash at end of the period | $655,233 | $621,733 |
| Supplementary information: | ||
| Interest paid in cash | $4,411 | $3,825 |
| Income tax paid in cash | 156 | 192 |
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2025
- ORGANIZATION AND BASIS OF PRESENTATION
Organization
Greenlight Capital Re, Ltd. (“GLRE” or “Parent” and, together with its wholly-owned subsidiaries, the “Company”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. The Company is a global specialty property and casualty reinsurer headquartered in the Cayman Islands. The ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”
Basis of Presentation
These unaudited condensed consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the U.S. Securities and Exchange Commission’s (“SEC”) instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s 2024 Form 10-K. The financial statements include the accounts of GLRE and the consolidated financial statements of its wholly-owned subsidiaries and all significant intercompany transactions and balances have been eliminated on consolidation.
In the opinion of management, these financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. The results of operations for any interim period are not necessarily indicative of the results for a full year.
Tabular dollars are in thousands, with the exception of per share amounts or otherwise noted. All amounts are reported in U.S. dollars.
Reclassifications
The following amounts in the prior period condensed consolidated financial statements have been reclassified to conform to the presentation of the current condensed consolidated financial statements:
The Company has reported separately “Underwriting expenses” from “Corporate and other expenses” in the condensed consolidated statements of operations, which were previously combined and reported as “General and administrative expenses”. This resulted in no change to the previously reported total expenses or net income.
The Company has reclassified investment-related income from Lloyd’s syndicates, which was previously presented in the condensed consolidated statements of operations under the caption “Other income, net”, to “Net investment income”. This resulted in no change to the previously reported total revenues or net income.
During 2025, the Company updated its definition of CAT event loss to be any individual CAT loss in excess of $5 million, net of reinsurance recoveries. For the various U.S. tornadoes (including severe convective storms), the Company has aggregated these and reported the total as CAT loss in Note 7 and under the “Corporate” column in the segment reporting tables in Note 16. Accordingly, the comparative prior year CAT loss disclosures have been recast to conform with this change.
- SIGNIFICANT ACCOUNTING POLICIES
There were no material changes to the Company’s significant accounting policies subsequent to its 2024 Form 10-K.
Recently Issued Accounting Standards Not Yet Adopted
In December 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures, which provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. While early adoption is permitted, a public company should apply the amendments prospectively. This ASU is effective for the Company’s 2025 year-end financial statements.
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024-03”). This ASU 2024-03 requires more detailed disclosures about the type of expenses (including purchases of inventory, employee compensation, and depreciation / amortization) in commonly presented expense captions in the consolidated income statements (e.g. cost of sales, general and administrative expenses, and research and development). ASU 2024-03 is effective for public business entities for fiscal years beginning after December 15, 2026, and interim periods within fiscal years after December 15, 2027. Early adoption is permitted.
The Company is currently evaluating the disclosure impact of the above new ASUs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.